Double punch for B-cell lymphomas: CAR T-cell innovation boosts efficacy, cuts toxicity
news-medical.net,
The Malaghan Institute of Medical Research in collaboration with Wellington Zhaotai Therapies Limited today announced results…
A Phase 1 Dose Escalation Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Intracellular Domains for Relapsed or Refractory B-Cell Non-Hodgkin…
Overview of attention for article published in Blood, November 2023
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
High Attention Score compared to outputs of the same age and source (95th percentile)
Readers on
- mendeley
- 7 Mendeley